This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Banchereau J, Steinman RM . Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.
Hagihara M, Shimakura Y, Tsuchiya T, Ueda Y, Gansuvd B, Munkhbat B et al. The efficient generation of CD83 positive immunocompetent dendritic cells from CD34 positive acute myelomonocytic or monocytic leukemia cells in vitro. Leuk Res 2001; 25: 249–258.
Woiciechowsky A, Regn S, Kolb H-J, Roskrow M . Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic response from patients with acute myeloid leukemia. Leukemia 2001; 15: 246–255.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Medicine 1985; 103: 620–625.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. The WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee, Airlie House, Virginia, November 1997. Histopathology 2000; 36: 69–86.
Maecker B, Mougiakakos D, Zimmermann M, Behrens M, Hollander S, Schrauder A et al. Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia 2006; 20: 645–649.
Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D et al. CD4+CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88: 941–955.
Fujii S-I, Shimizu K, Koji F, Kawano F . Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential. J Leuk Biol 2003; 73: 82–90.
Acknowledgements
This study was supported by the Foundation ‘Città della Speranza’, a grant from the ‘Regione Sicilia’, a grant from the ‘Associazione Italiana Ricerca sul Cancro’ (AIRC) 2005-2007, and in part by CNR and MIUR 2003.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Rights and permissions
About this article
Cite this article
Nigro, L., Sainati, L., Leszl, A. et al. Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation. Leukemia 21, 360–362 (2007). https://doi.org/10.1038/sj.leu.2404480
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404480